Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced, EHR-Facilitated Cancer Symptom Control (E2C2) Trial

NCT03892967 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03892967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced, EHR-Facilitated Cancer Symptom Control (E2C2) Trial
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
March 28, 2019
Completion date
January 31, 2023
Enrollment
50,207 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm